Schulz, H.; Schmoeckel, E.; Kuhn, C.; Hofmann, S.; Mayr, D.; Mahner, S.; Jeschke, U.
Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients. Int. J. Mol. Sci. 2017, 18, 1230.
https://doi.org/10.3390/ijms18061230
AMA Style
Schulz H, Schmoeckel E, Kuhn C, Hofmann S, Mayr D, Mahner S, Jeschke U.
Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients. International Journal of Molecular Sciences. 2017; 18(6):1230.
https://doi.org/10.3390/ijms18061230
Chicago/Turabian Style
Schulz, Heiko, Elisa Schmoeckel, Christina Kuhn, Simone Hofmann, Doris Mayr, Sven Mahner, and Udo Jeschke.
2017. "Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients" International Journal of Molecular Sciences 18, no. 6: 1230.
https://doi.org/10.3390/ijms18061230
APA Style
Schulz, H., Schmoeckel, E., Kuhn, C., Hofmann, S., Mayr, D., Mahner, S., & Jeschke, U.
(2017). Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients. International Journal of Molecular Sciences, 18(6), 1230.
https://doi.org/10.3390/ijms18061230